Finally, PORCN inhibition significantly suppressed PDX tumor development of RNF43‐mutant CRC cells, suggesting that PORCN inhibitors are an effective therapeutic strategy against RNF43‐mutant CRC development and metastasis. The gene discussed is RNF43; the disease is colorectal carcinoma.